A detailed history of Rps Advisory Solutions LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Rps Advisory Solutions LLC holds 998 shares of LLY stock, worth $794,078. This represents 0.63% of its overall portfolio holdings.

Number of Shares
998
Previous 1,035 3.57%
Holding current value
$794,078
Previous $937 Million 5.68%
% of portfolio
0.63%
Previous 0.86%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

SELL
$772.14 - $960.02 $28,569 - $35,520
-37 Reduced 3.57%
998 $884 Million
Q2 2024

Jul 25, 2024

BUY
$724.87 - $909.04 $750,240 - $940,856
1,035 New
1,035 $937 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Rps Advisory Solutions LLC Portfolio

Follow Rps Advisory Solutions LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rps Advisory Solutions LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rps Advisory Solutions LLC with notifications on news.